Podcasts

Drs Armstrong and Tawagi provide a comprehensive review of metastatic urothelial carcinoma management.

Megan Kruse, MD, discusses the evolving role of FES-PET/CT in breast cancer, particularly invasive lobular carcinoma.

Dr Cooper discusses recent advances that have reshaped the treatment paradigm for small cell lung cancer, particularly in the relapsed setting.

Drs Nunnery and Kang discuss the rapidly evolving treatment paradigm for first-line metastatic TNBC, including the emergence of novel ADCs.

Drs Camidge and Meguid discuss Dr Meguid’s journey into medicine, his surgical interests, and how personal experiences shape perspectives on patient care.

Drs Matulonis and Stover explore the biology and therapeutic relevance of the RAS/MAP kinase pathway in gynecologic cancers.

Drs Nunnery and Iyengar highlight the evolving integration of GLP-1 agonists into the breast cancer treatment armamentarium.

Camidge and O'Donnell discussed O’Donnell’s career, which has culminated in his role as director of Research Partnerships at Cancer Research Society.

Dr Shadman discusses an indirect comparison evaluating zanubrutinib vs acalabrutinib plus venetoclax in chronic lymphocytic leukemia.

Drs Nunnery and Iyengar discuss lifestyle and medical interventions pertinent to breast cancer survivorship.

Camidge and Alvarez discussed Alvarez's career path, which has spanned roles from homicide detective to trial lawyer specializing in tobacco litigation.

Quinto Gesiotto, MD, discusses optimal ponatinib dosing strategies and evolving TKI sequencing considerations in chronic myeloid leukemia.